WO2001028526A3 - Gastroresistant tablets for alimentary, dietetic and therapeutic use - Google Patents

Gastroresistant tablets for alimentary, dietetic and therapeutic use Download PDF

Info

Publication number
WO2001028526A3
WO2001028526A3 PCT/IT2000/000424 IT0000424W WO0128526A3 WO 2001028526 A3 WO2001028526 A3 WO 2001028526A3 IT 0000424 W IT0000424 W IT 0000424W WO 0128526 A3 WO0128526 A3 WO 0128526A3
Authority
WO
WIPO (PCT)
Prior art keywords
alimentary
formulation
dietetic
therapeutic use
active principle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IT2000/000424
Other languages
French (fr)
Other versions
WO2001028526A2 (en
Inventor
Alessandro Seneci
Pia Alberico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Truffini and Regge' Farmaceutici Srl
Original Assignee
Truffini and Regge' Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truffini and Regge' Farmaceutici Srl filed Critical Truffini and Regge' Farmaceutici Srl
Priority to EP00974794A priority Critical patent/EP1225876B1/en
Priority to AT00974794T priority patent/ATE259221T1/en
Priority to AU13000/01A priority patent/AU1300001A/en
Priority to DE60008276T priority patent/DE60008276T2/en
Publication of WO2001028526A2 publication Critical patent/WO2001028526A2/en
Publication of WO2001028526A3 publication Critical patent/WO2001028526A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A novel formulation for oral use is described, said formulation containing at least one active principle with a pharmaceutical, dietary or alimentary action, in combination with at least one fat and/or phospholipid in an amount of between 5 and 30 %, relative to the weight of the formulation; this formulation allows the slow release, over time, of the active principle under physiological conditions which simulate the digestive processes which normally take place in the stomach.
PCT/IT2000/000424 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use Ceased WO2001028526A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00974794A EP1225876B1 (en) 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use
AT00974794T ATE259221T1 (en) 1999-10-21 2000-10-20 ENTERIC JUICE RESISTANT TABLET FOR FOOD, DIET AND THERAPY
AU13000/01A AU1300001A (en) 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use
DE60008276T DE60008276T2 (en) 1999-10-21 2000-10-20 STOMACH-RESISTANT TABLET FOR FOOD, DIET AND THERAPY

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002206A IT1315252B1 (en) 1999-10-21 1999-10-21 GASTRORESISTANT TABLETS FOR FOOD OR DIET USE, OBTAINED THROUGH GROUND MIXED FATS
ITMI99A002206 1999-10-21

Publications (2)

Publication Number Publication Date
WO2001028526A2 WO2001028526A2 (en) 2001-04-26
WO2001028526A3 true WO2001028526A3 (en) 2001-12-06

Family

ID=11383827

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IT2000/000424 Ceased WO2001028526A2 (en) 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use

Country Status (7)

Country Link
EP (1) EP1225876B1 (en)
AT (1) ATE259221T1 (en)
AU (1) AU1300001A (en)
DE (1) DE60008276T2 (en)
ES (1) ES2215079T3 (en)
IT (1) IT1315252B1 (en)
WO (1) WO2001028526A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028877B2 (en) 2007-03-28 2015-05-12 Aker Biomarine Antarctic As Bioeffective krill oil compositions

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20300304U1 (en) * 2003-01-09 2003-04-24 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Ocuvite zinc
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
EP2022503B1 (en) * 2007-08-07 2011-10-19 Symrise AG Encapsulated vaccine extracts with balanced intestinal release
US8372812B2 (en) 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
HRP20240090T1 (en) 2014-09-22 2024-04-26 Ntc S.R.L. COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS
PL3256003T5 (en) 2015-02-11 2025-11-17 Aker Biomarine Human Ingredients As Lipid extraction processes
WO2016128838A2 (en) 2015-02-11 2016-08-18 Aker Biomarine Antarctic As Lipid compositions
ITUB20153066A1 (en) 2015-08-11 2017-02-11 Graal S R L FOOD AND / OR NUTRACEUTICAL COMPOSITION CONTAINING PEA
CA3047926A1 (en) * 2017-01-20 2018-07-26 Kaneka Corporation Glutathione-containing granular fertilizer
CA3087126A1 (en) 2017-12-27 2019-07-04 Graal S.R.L. Process for the preparation of delayed release solid formulations
CN112618500B (en) * 2020-12-24 2022-12-09 广州汉光药业股份有限公司 Folic acid preparation and preparation method thereof
JP2022102198A (en) * 2020-12-25 2022-07-07 ライオン株式会社 Oral solid preparation
IT202200022413A1 (en) * 2022-10-31 2024-05-01 S I I T S R L Servizio Int Imballaggi Termosaldanti Multilayer gummy with differentiated release of active ingredients

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3914622A1 (en) * 1989-05-03 1990-11-08 Fiegert Seibt Edda Dr Rer Nat Prodn. of solid pharmaceutical or cosmetic compsns. - by extracting plants, animal organs and/or tissue cultures, opt. concentrating extract and mixing with lipophilic carrier
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
GB2305604A (en) * 1995-09-29 1997-04-16 Quest Vitamins Ltd Carrier base materials comprising hydroxypropylmethylcellulose and lecithin
WO1998035656A1 (en) * 1997-02-12 1998-08-20 R. P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3914622A1 (en) * 1989-05-03 1990-11-08 Fiegert Seibt Edda Dr Rer Nat Prodn. of solid pharmaceutical or cosmetic compsns. - by extracting plants, animal organs and/or tissue cultures, opt. concentrating extract and mixing with lipophilic carrier
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
GB2305604A (en) * 1995-09-29 1997-04-16 Quest Vitamins Ltd Carrier base materials comprising hydroxypropylmethylcellulose and lecithin
WO1998035656A1 (en) * 1997-02-12 1998-08-20 R. P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028877B2 (en) 2007-03-28 2015-05-12 Aker Biomarine Antarctic As Bioeffective krill oil compositions
US9034388B2 (en) 2007-03-28 2015-05-19 Aker Biomarine Antartic As Bioeffective krill oil compositions
US9072752B1 (en) 2007-03-28 2015-07-07 Aker Biomarine Antarctic As Bioeffective krill oil compositions
US9078905B2 (en) 2007-03-28 2015-07-14 Aker Biomarine Antarctic As Bioeffective krill oil compositions
US9119864B2 (en) 2007-03-28 2015-09-01 Aker Biomarine Antarctic As Bioeffective krill oil compositions
US9320765B2 (en) 2007-03-28 2016-04-26 Aker Biomarine Antarctic As Bioeffective krill oil compositions
US9375453B2 (en) 2007-03-28 2016-06-28 Aker Biomarine Antarctic As Methods for producing bioeffective krill oil compositions

Also Published As

Publication number Publication date
ES2215079T3 (en) 2004-10-01
EP1225876B1 (en) 2004-02-11
ITMI992206A0 (en) 1999-10-21
DE60008276D1 (en) 2004-03-18
WO2001028526A2 (en) 2001-04-26
DE60008276T2 (en) 2004-12-16
AU1300001A (en) 2001-04-30
EP1225876A2 (en) 2002-07-31
IT1315252B1 (en) 2003-02-03
ATE259221T1 (en) 2004-02-15
ITMI992206A1 (en) 2001-04-21

Similar Documents

Publication Publication Date Title
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
US10646510B2 (en) Aerated confectionaries comprising shelf-stable active ingredients
KR101190791B1 (en) Compositions and methods for the sustained release of beta-alanine
CA2229624A1 (en) Method of reducing bodyweight and treating obesity
AU7848187A (en) Pharmaceutical formulations
CA2229279A1 (en) Nutritional and/or dietary composition and method of using the same
TNSN99163A1 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL-CARNITINE AND α -LIPOIC ACID WHICH IMPROVES THE METABOLIC USE OF GLUCOSE
EP0764405A3 (en) Nutritional composition
EP1176948A1 (en) Anti-nausea compositions and methods
EP0246294B1 (en) Use of a hydrophobic substance for preparing an enteric preparation for treatment of obesity and an enteric preparation
KR20070111478A (en) Compositions and Methods for Nutritional Supplements
SI1181047T1 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
US10201498B2 (en) Shelf-stable foam-like confectionaries comprising erythritol and active ingredients
WO2006016363A3 (en) Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
CA2285552A1 (en) Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
CA2386770A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
AU777971B2 (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease
EP1393738A4 (en) ANTIDIABETIC TREATMENT
IT1314199B1 (en) COMPOSITIONS CONTAINING SUBSTANCES TO ADRENERGIC AND ESTRATTIVEGETALI FOR THE TREATMENT OF OVERWEIGHT AND OBESITY
AU571641B2 (en) Dietry dextran formulations
ES2107437T3 (en) PRODUCT FOR ORAL INGESTION.
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
CA2285550A1 (en) Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
CA2286631A1 (en) Solid compositions suitable for oral administration comprising l-carnitine or an alkanoyl-l-carnitinecholine tartrate
Elperin et al. A patient's guide to protease inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000974794

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10089262

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000974794

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000974794

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP